63rd Annual William J. Holloway Infectious Disease Symposium

63rd Annual William J. Holloway Infectious Disease Symposium

Thursday, May 7, 2026; 9:00am - 4:15pm EST

In Person: ChristianaCare Ammon Center
4755 Ogletown-Stanton Rd, Newark, DE 19718

Virtual Option (first come basis, limited spots available)
Zoom Videoconferencing

Registration is required. No late registrations will be accepted!

Registration deadline: April 30, 2026

Overview

The Annual William J. Holloway Infectious Disease Symposium continues its tradition of delivering timely, evidence-based education on important infectious disease topics. This year’s program will focus on updated pneumonia management guidelines, emerging diagnostic technologies, and the integration of new and existing testing methods into clinical practice. Additionally, the symposium will address infectious disease considerations in patients with substance use disorders, providing practical guidance to enhance patient care and outcomes.
 

Target Audience

This activity is intended for primary care physicians, specialty physicians, pharmacists, residents, medical students, physician assistants, nurses, and nurse practitioners.

Statement of Need

Clinicians demonstrate limited awareness of updated pneumonia guidelines, particularly the recommendations for shorter antibiotic durations. Additional gaps exist in knowledge and application of new and existing infectious disease testing methods. These deficiencies stem from recent advances in diagnostic technology and evolving clinical evidence. Education is needed to support effective integration of current guidelines and diagnostic strategies into clinical practice to improve patient care outcomes.

Educational Objectives

Upon completion of this activity learners should be able to:

1. Describe current recommendations for pneumonia management based on updated guidelines and discuss areas of ongoing debate or uncertainty in clinical practice.
2. Identify emerging diagnostic testing strategies and review existing infectious disease tests, with emphasis on appropriate application in patient evaluation.
3. Recognize infectious disease risks specific to patients with substance use disorders and outline evidence-based approaches to their management.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of Delaware and ChristianaCare. The Medical Society of Delaware is accredited by the ACCME to provide continuing medical education for physicians.
It is the policy of the Medical Society of Delaware (MSD) to comply with the ACCME Standards for Integrity and Independence in Accredited Continuing Education (CME). In keeping with these standards, all faculty participating in continuing medical education provided by MSD are expected to disclose to the activity audience any relevant financial relationships.
Joint providership of CME by MSD in no way implies endorsement of any product or service.

This activity is not supported by commercial funding. 

Credit Designation Statement

The Medical Society of Delaware designates this live activity for a maximum of 6 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity session enables the participant to earn up to 6 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.  Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity.  It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points. 

Upon successful completion of this course, the Medical Society of Delaware (MSD) will submit your completion data to ABIM via ACCME’s Program and Activity Reporting System (PARS) for MOC points.
 

Faculty and Disclosures

In accordance with the appropriate accrediting bodies, all planners, teachers, and authors with control over activity content are required to disclose to the provider any relevant financial relationships (those held by the planner or significant other, currently or within the last 24 months) with commercial interests/ineligible companies. Accredited providers are required to provide this information to learners before the start of an activity.

The following is a list of the faculty, along with any information they have disclosed regarding their relevant financial relationships.

Chad Duffalo, MD, MPH (Planner, Activity Director, Chair) - has no relevant financial relationship(s) with ineligible companies to disclose
David M. Cohen, MD (Planner, Moderator) - has no relevant financial relationship(s) with ineligible companies to disclose
Amy Minsker (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose
Erica Wilson, BSHS (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose
Clint Joseph Borja, PharmD, BCIDP (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose
Marci Drees, MD, MS (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose
Nicole Harrington, PharmD (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose
Lynn Schaeffer, BS (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose
Omar Khan MD. MHS, FAAFP (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose
John F. Reinhardt, MD (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose
Pamela Bailey (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose
Tara L. Owens (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose

Francesca Lee, MD (Speaker/Presenter) - has no relevant financial relationship(s) with ineligible companies to disclose
Hon. Keith Martin, MD, PC (Speaker/Presenter) - has no relevant financial relationship(s) with ineligible companies to disclose

Michael Klompas MD, MPH, FIDSA, FSHEA (Speaker/Presenter) - received grant funding from Centers for Disease Control and Prevention, Agency for Healthcare Research and Quality, Massachusetts Department of Public Health; received royalties from UpToDate for chapters on pneumonia - All of the relevant financial relationships listed for this individual have been mitigated.

Paul G. Auwaerter, MD, MBA, FIDSA, FACP (Speaker/Presenter) - on advisory board for Shionogi (COVID); received research grant from Pfizer (Lyme); consultant for Tarsus Pharmaceuticals (tickborne diseases); publicly traded ownership of Johnson & Johnson; equity from Capricor (Board of Directors, Duchenne Muscular Dystrophy) - All of the relevant financial relationships listed for this individual have been mitigated.

Sara K Schultz, MD, FACP, FIDSA, FCPP (Speaker/Presenter) - has no relevant financial relationship(s) with ineligible companies to disclose
Phoebe Holmes, MD (Presenter/Panelist) - has no relevant financial relationship(s) with ineligible companies to disclose
Victoria Powell, MD, MPH (Presenter/Panelist) - has no relevant financial relationship(s) with ineligible companies to disclose
Vinay K. Gheyi, MD (Speaker/Presenter, Panelist) - has no relevant financial relationship(s) with ineligible companies to disclose

Disclaimer

All information contained within this activity is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained in this educational activity. No single reference or service can take the place of medical training, education and experience. This educational event does not define a standard of care, nor is it intended to dictate an exclusive course of management. This information should not substitute for a visit or consultation with a health care provider.

Technical Requirements

This activity is best experienced using the most current browser of Firefox, Chrome, Safari, or Microsoft Edge. Avoid using public or hospital Wi-Fi when accessing your account. For all activities featuring audio you must have a sound card and speakers. To view graphic images and references that appear in separate "pop-up" windows, you must have JavaScript and session cookies enabled on your computer. Adobe Acrobat Reader may be required for certain activities.

Select the Continue button below to begin. You may return later if you are unable to complete the activity at this time.